polyol

aldo-keto reductase family 1 member B ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35356240 Inhibition of Aldose Reductase by Novel Phytocompounds: A Heuristic Approach to Treating Diabetic Retinopathy. 2022 2
2 35454074 In Search of Differential Inhibitors of Aldose Reductase. 2022 Mar 22 1
3 33109031 Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions. 2021 2
4 33494154 Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems. 2021 Jan 21 1
5 34066081 Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications. 2021 May 12 2
6 34279787 Aldose Reductase: a cause and a potential target for the treatment of diabetic complications. 2021 Jul 1
7 34314916 Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation. 2021 Oct 2
8 34677370 Physiological and Pathological Roles of Aldose Reductase. 2021 Sep 27 2
9 34768205 Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase. 2021 Dec 2
10 32463711 Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme: in vitro and in silico study. 2020 May 28 2
11 32602375 Addressing selectivity issues of aldose reductase 2 inhibitors for the management of diabetic complications. 2020 Jul 2
12 32628753 Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway. 2020 Sep 24 1
13 32640594 Aldose Reductase Differential Inhibitors in Green Tea. 2020 Jul 6 2
14 33069193 Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review. 2020 2
15 33158254 (5-Hydroxy-4-oxo-2-styryl-4H-pyridin-1-yl)-acetic Acid Derivatives as Multifunctional Aldose Reductase Inhibitors. 2020 Nov 4 2
16 33374137 Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy Collateral Glucose-Utilizing Pathways in Diabetic Polyneuropathy. 2020 Dec 24 1
17 31636082 Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. 2019 Nov 11 1
18 31723418 Human aldose reductase unfolds through an intermediate. 2019 1
19 29190815 Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion. 2017 1
20 19383984 Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway. 2009 Jul 3 1
21 19480738 Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway. 2009 Jun 1 4
22 20021424 Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies. 2008 Jan 1
23 16297625 Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors. 2006 Feb 1
24 14751239 Polyol pathway-dependent osmotic and oxidative stresses in aldose reductase-mediated apoptosis in human lens epithelial cells: role of AOP2. 2004 Feb 20 2
25 12604218 Up-regulation of aldose reductase by the substrate, methylglyoxal. 2003 Feb 1 3
26 12615520 Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy. 2003 Apr 2
27 11302779 Natural therapies for ocular disorders, part two: cataracts and glaucoma. 2001 Apr 1
28 11862253 The Effect of Urinary pH and Flow Rate on the Renal Elimination of Zopolrestat and Zopolrestat Glucuronide in Humans. 1996 Mar 1
29 8330752 Peripheral nerve protein glycation and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS. 1993 Jan-Feb 1
30 1410879 [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors]. 1992 Jan-Feb 1
31 2115448 A thirty year journey in the polyol pathway. 1990 Jun 2
32 6086432 Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. 1984 Aug 1